Thomas Graeber (@graeber_thomas) profile picture

Thomas Graeber

@graeber_thomas
Joined August 2012
  • Tweets232
  • Following304
  • Followers218
12Media
Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)Photo by Thomas Graeber (@graeber_thomas)
Sharing new insight and data on the cancer transdifferentiation therapy resistance escape route. Congratulations to Olga and team for their contributions to the field. linkedin.com/posts/olga-chen…
#transdifferentiation #prostatecancer #cancercell #multiomics | Olga Chen

#transdifferentiation #prostatecancer #cancercell #multiomics | Olga Chen

I am excited to share that my thesis project on the #transdifferentiation of #prostatecancer is now published in #CancerCell. We characterized how adenocarcinoma cells become aggressive small cell...

linkedin.com
5
12
3
51
8,971
ICYMI in @CD_AACR, related to Scott Lowe’s presentation at the Scientific Committee on Myeloid Neoplasia session at #ASH19 ⁦@EvangeliaLoizou⁩ ⁦@LoweLabMSKCC⁩ cancerdiscovery.aacrjournals…
1
4
20
Thomas Graeber retweeted
Yale Cancer Center (@YaleCancer) profile picture
Yale Cancer Center
@YaleCancerJan 15
Thank you to Dr. Scott Lowe @LoweLabMSKCC @MSKCancerCenter for presenting #GrandRounds on potential programs to reveal and exploit the strategies nature uses to combat #cancer, including the impact of #p53 in #tumorsuppression. Watch his full talk youtube.com/watch?v=B6pji1_x…. @SmilowCancer
Image from Yale Cancer Center (@YaleCancer)
3
16
768
Thomas Graeber retweeted
Cell (@CellCellPress) profile picture
Cell@CellCellPressApr 15
Now online! Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant transition dlvr.it/TS3R9B
Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant...

Oncogenic and tumor-suppressive forces converge on a progenitor niche at the benign-to-malignant...

Opposing oncogenic and tumor-suppressive forces establish a progenitor-like state that builds a self-reinforcing niche to drive benign-to-malignant transition in pancreatic cancer models. Disruption...

cell.com
31
2
87
8,770
“You know everyone is tough when they are at home in front of a computer” - Charles Barkley.
1
1
109
We’re in the field for real, UCLA Bruins 🐻 #GoBruins
Image from UCLA Women's Basketball (@UCLAWBB)
19
94
5
963
25,015
Excited to present our data using spatial biology to characterize the tumor immune microenvironment of non-melanoma skin cancer! Talk is tomorrow 9/29 10:12am MBCC Room 208. #OTOMTG24
Image from Jenny Anderson, MD, PhD (@jlandrson)
2
10
854
Super excited to share that we’ve moved to Yale University’s Department of Urology to continue our prostate cancer research. Already loving the Yale community and looking forward to some awesome collaborations ahead. @Yale_Urology @YaleMed @YaleCancer @Yale
Image from Ping Mu 🇺🇦 (@PingMu_PhD)
20
10
1
177
10,794
Sarcoma is a type of cancer that is often hard to treat. New research may change that. Read about @UCD_Cancer's collaboration with @UCLAHealth and how it is getting us closer to finding a cure. ucdavis.health/47wlDza @UCDavisHealth #sarcoma
4
2
8
1,072
Thomas Graeber retweeted
Anton Henssen (@anton_gh) profile picture
Anton Henssen@anton_gh13 Aug 2024
🔥Excited to share @mada48422514 Decoil out today @genomeresearch If you have Nanopore genome sequencing and want to study the structural heterogeneity of ecDNA, try it. Thank you to all the collaborators @CancerGrand team eDyNAmiC, @MDC_Berlin @ChariteBerlin @MSKCancerCenter
Cancer Grand Challenges (@CancerGrand) profile pictureCancer Grand Challenges
@CancerGrand13 Aug 2024
Team eDyNAmiC has developed Decoil, a tool allowing reconstruction of co-occurring complex ecDNAs from long-read sequencing data 🧬 In @genomeresearch, they demonstrate its utility by uncovering ecDNA structural heterogeneity in neuroblastoma 👉 doi.org/10.1101/gr.279123.12…
2
13
1
43
5,648
Honored to receive such an acknowledgment & excited to share what I have learned about #plasticity in the @charlesrudin lab at @MSKCancerCenter during the last 6 years! #LCSM. Also thanks to @LungAssociation and @EGFRResisters for funding some of the work I will present.
Science Translational Medicine (@ScienceTM) profile pictureScience Translational Medicine@ScienceTM12 Aug 2024
🎉 Congratulations to @AlvaroQuintanal, winner of the 2024 @AAAS Martin and Rose Wachtel Cancer Research Award. RSVP for free to hear his lecture on his prize-winning work this Friday, 16 August at 12 p.m. ET, at the NIH or via livestream: scim.ag/80g
Image from Science Translational Medicine (@ScienceTM)
17
11
3
98
28,803
🤣¡Definitivamente nadie esperaba este encuentro! @SnoopDogg está en París como parte de la cobertura olímpica de NBC, donde se encontró con @AndresCantorGOL 🎤🎶 🗣️ ¡Y cantaron un gol juntos! Imperdible el momento: #OlimpicosTelemundo #ParisOlympics
8
165
41
679
76,619
Inspirational passion. teapawt.net/mellomusicgroup/status…
2
116
Thomas Graeber retweeted
Lai (Linda) Chan (@LindaCPhD) profile picture
Lai (Linda) Chan@LindaCPhD4 Mar 2024
A new study elucidated the role of the epigenetic reader Tudor domain in leukemia progression and leveraged CRISPR-SADD to identify a lead compund targeting the Tudor domain. 👇 Congrats Anthony! #AcademicTwitter science.org/doi/10.1126/scia…
Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery

Therapeutic targeting Tudor domains in leukemia via CRISPR-Scan Assisted Drug Discovery

CRISPR-SADD pipeline identifies SGF29 Tudor domain inhibitor for leukemia therapy.

science.org
5
6
1,133
Thomas Graeber retweeted
Ping Mu 🇺🇦 (@PingMu_PhD) profile picture
Ping Mu 🇺🇦@PingMu_PhD9 Apr 2024
Our new paper was published online today at @CD_AACR. If you are attending #AACR2024, please visit our poster today to hear the first author, Dr. Yaru Xu, discuss her fascinating work. @PCF_Science @utswcancer
Image from Ping Mu 🇺🇦 (@PingMu_PhD)
Image from Ping Mu 🇺🇦 (@PingMu_PhD)
6
17
2
77
8,505
Thomas Graeber retweeted
Anton Henssen (@anton_gh) profile picture
Anton Henssen@anton_gh10 Apr 2024
Great work !!
Garnett Lab (@Garnettlab) profile pictureGarnett Lab@Garnettlab9 Apr 2024
Our work 'Novel WRN Helicase Inhibitors Selectively Target Microsatellite Unstable Cancer Cells' is published today in @CD_AACR (aacrjournals.org/cancerdisco…). Using genetic tools, in 2019 @DepMapSanger and others reported WRN as a synthetic-lethal target in MSI cell line. 1/5
Image from Garnett Lab (@Garnettlab)
1
2
841
Of the 9 Educational Sessions this morning, I decided to attend the lineage plasticity and resistance. Session Chaired by Dr. Charlie Rudin @AACR #AACR24
Image from Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry)
Image from Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry)
Image from Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry)
Image from Wafik S. El-Deiry, MD, PhD, FACP (@weldeiry)
1
7
29
5,991
The Kat is out of the bag! globenewswire.com/news-relea…
Auron Announces Poster Presentations at 2024 AACR Annual Meeting

Auron Announces Poster Presentations at 2024 AACR Annual Meeting

NEWTON, Mass., March 06, 2024 (GLOBE NEWSWIRE) -- Auron Therapeutics, a biotechnology company focused on developing next-generation targeted therapies by...

globenewswire.com
7
170
🔥New study from lab that found ATGL, a mediator of intracellular lipolysis, is 📈in mCRPC, regulated by #CAMKK2 #AMPK, and a druggable target for advanced #prostatecancer. Both lipolytic and non-lipolytic roles of ATGL are key. @MDAndersonNews @CR_AACR bit.ly/3NfF5az
Graphical Abstract

ALT Graphical Abstract

Figure 2: ATGL regulates glycerophospholipid levels in human CRPC xenografts.

ALT Figure 2: ATGL regulates glycerophospholipid levels in human CRPC xenografts.

7
19
4
79
14,199
Thomas Graeber retweeted
Cancer Discovery (@CD_AACR) profile picture
Cancer Discovery@CD_AACR8 Dec 2023
Read this week's Cancer Discovery #ResearchWatch: ASCL1 and ASCL2 Define Distinct States of Neuroendocrine #ProstateCancer, a summary of the paper by Chia-Chun Chen, Owen Witte, @graeber_thomas et al. bit.ly/3GzGODX @UCLAstemcell @UCLAJCCC
Image from Cancer Discovery (@CD_AACR)
1
4
11
1,869
Load more